Angiology
Gore Receives FDA Approval for Next Generation of Large Diameter GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface: Improved Design Now Available with Lower Profile Delivery System for Use in Iliac Arteries
Published in Medical Device Business Week, August 19th, 2009
W. L. Gore & Associates (Gore)announced that it has received approval from the US Food and Drug Administration (FDA) to market the most up-to-date design for the GORE VIABAHN® Endoprosthesis for device diameters 9 - 13 mm. The next generation of the large diameter product enables streamlined deployment on the same 0.035" guidewire and TIP to HUB direction as the 5 - 8 mm sizes. Additional modifications to the large diameter GORE VIABAHN Endoprosthesis include radial device expansion, a contoured proximal edge and a lower profile that is now available for most sizes.
"The self-expanding, covered, GORE VIABAHN Endoprosthesis offers elegant and versatile endovascular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Adenoidectomy
PEAK Surgical Introduces PEAK PlasmaBlade(TM) TnA - AGA Medical Holdings, Inc.
AGA Medical Patent Declared Valid in U.K. Patent Infringement Lawsuit against Occlutech - American Medical Systems Holdings, Inc.
American Medical Systems Announces Second Quarter 2009 Financial Results - American Society for Radiation Oncology
Breast Cancer Radiation Guidelines Called Positive Step - Angeion Corporation
Angeion to Announce 2009 Third-Quarter Results on Wednesday, August 26 - Aradigm Corporation
Zogenix Announces Exclusive Co-Promotion Agreement in U.S. for Sumavel(TM) DosePro(TM) - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
